-transparent.png){kind=logo}
Gm phenotype G1m 1,2, and 3 frequencies were examined in 103 Finnish myasthenia gravis patients. There were no significant differences as compared with the expected frequency, either in the total material or when patients were subdivided according to sex, age of onset of disease, thymus pathology, or presence of HLA-B8. However, individuals with Gm(+1) had a significantly higher concentration of antibodies against acetylcholine receptor, possibly indicating a correlation with severity of disease.
Related Publications
C I Smith, and
R Grubb, and
L Hammarström, and
R Pirskanen
March 1980,
Lancet (London, England),
C I Smith, and
R Grubb, and
L Hammarström, and
R Pirskanen
January 1997,
Autoimmunity,
C I Smith, and
R Grubb, and
L Hammarström, and
R Pirskanen
June 1990,
Journal of autoimmunity,
C I Smith, and
R Grubb, and
L Hammarström, and
R Pirskanen
January 1987,
Neurologija,
C I Smith, and
R Grubb, and
L Hammarström, and
R Pirskanen
February 1988,
Journal of neurology, neurosurgery, and psychiatry,
C I Smith, and
R Grubb, and
L Hammarström, and
R Pirskanen
November 1977,
Acta neurologica Scandinavica,
C I Smith, and
R Grubb, and
L Hammarström, and
R Pirskanen
July 1975,
Humangenetik,
C I Smith, and
R Grubb, and
L Hammarström, and
R Pirskanen
February 1993,
Scandinavian journal of immunology,
C I Smith, and
R Grubb, and
L Hammarström, and
R Pirskanen
September 1983,
The New England journal of medicine,
C I Smith, and
R Grubb, and
L Hammarström, and
R Pirskanen
October 2003,
Archives of neurology,
